Vialwirebiotech, curated
October 1, 2026, 7:51 AM
August 4, 2026
- 5:30 AM · Drug Discovery World5:30 AMNRG Therapeutics appoints neuroscience leader as CMO — Drug Discovery World
- 5:19 AM · Pharmaceutical Technology5:19 AMFDA grants breakthrough therapy designation to Lilly’s olomorasib — Pharmaceutical Technology
- 4:15 AM · Drug Discovery World4:15 AM$5 million private placement supports norovirus programme — Drug Discovery World
August 3, 2026
- 4:56 PM · STAT News4:56 PMSTAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case — STAT News
- 11:49 AM · BioPharma Dive11:49 AMBioNTech taps Sobi executive Oelkers as its next CEO — BioPharma Dive
- 11:41 AM · STAT News
- 11:30 AM · Drug Discovery World11:30 AMRactigen Therapeutics closes over $31 million financing — Drug Discovery World
- 10:18 AM · Drug Discovery World10:18 AMBasking Biosciences reports promising stroke therapy results — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMCSPC Zhongqi Pharmaceutical Technology identifies new antivirals for RSV — BioWorld
- 9:00 AM · BioWorld9:00 AMVelavigo describes new bispecific ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMNew ITGA2-targeting ADCs reported in Inxmed patent — BioWorld
- 9:00 AM · BioWorld9:00 AMIND open for Ractigen’s RAG-1C in proliferative vitreoretinopathy — BioWorld
- 9:00 AM · BioWorld9:00 AMChina IND nod for Leads Biolabs’ LBL-024 in colorectal cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Apeiron Biotechnology describes new KIF18A inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMAdlai Nortye’s AN-4035 gains Australian HREC approval — BioWorld
- 9:00 AM · BioWorld9:00 AMEli Lilly synthesizes new GLP-1R agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMNabsys enters electronic genome mapping collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMSHY-ONC6 effects tumor regression via 19S inhibition — BioWorld
- 8:30 AM · SCMP — Tech8:30 AMChinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny — SCMP — Tech
- 8:12 AM · STAT News
- 7:01 AM · Drug Discovery World7:01 AMFDA rejects Capricor Therapeutics’ Duchenne muscular dystrophy drug — Drug Discovery World
- 5:29 AM · Pharmaceutical Technology5:29 AMIMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib — Pharmaceutical Technology
- 5:06 AM · Drug Discovery World5:06 AMMyqorzo gets concurrent approvals from UK’s MHRA and NICE — Drug Discovery World
- 4:45 AM · Pharmaceutical Technology4:45 AMRatio Therapeutics secures $70m Series C funding for cancer radiotherapy — Pharmaceutical Technology
- 4:05 AM · Drug Discovery World4:05 AMProcessa Pharmaceuticals buys Vidya Therapeutics — Drug Discovery World
August 2, 2026
- 2:14 PM · STAT News2:14 PMSTAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricing — STAT News